Announced

Permira-backed Neuraxpharm completed the acquisition of Medinutrix.

Synopsis

Permira-backed Neuraxpharm, an European specialty pharmaceutical company, completed its acquisition of Medinutrix, an Irish pharma company.Financial terms were not disclosed. “When we founded Medinutrix, we dedicated ourselves to be a specialty pharmaceutical company delivering real value to patients and healthcare professionals. We are enthusiastic about our future as Neuraxpharm Ireland and the opportunity to work with such a dynamic and experienced team, to bring further innovative medicines to patients in Ireland,” Dave Shanahan, Medinutrix Founder.

Principals

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US